April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Relationship between retinal venous tortuosity and aqueous vascular endothelial growth factor concentration in eyes with central retinal vein occlusion
Author Affiliations & Notes
  • Shunsuke Yasuda
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Shu Kachi
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Mineo Kondo
    Ophthalmology, Mie University Graduate School of Medicine, Tsu, Japan
  • Yuki Tamai
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Shinji Ueno
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Hiroko Terasaki
    Ophthalmology, Nagoya University Graduate School of Medicine, Nagoya, Japan
  • Footnotes
    Commercial Relationships Shunsuke Yasuda, None; Shu Kachi, None; Mineo Kondo, None; Yuki Tamai, None; Shinji Ueno, None; Hiroko Terasaki, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3870. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shunsuke Yasuda, Shu Kachi, Mineo Kondo, Yuki Tamai, Shinji Ueno, Hiroko Terasaki; Relationship between retinal venous tortuosity and aqueous vascular endothelial growth factor concentration in eyes with central retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3870.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Retinal venous tortuosity is a risk factor for the development of iris neovascularization (NVI) in eyes with a central retinal vein occlusion (CRVO). It is also known that the increased level of ocular vascular endothelial growth factor (VEGF) is associated with NVI. Thus, the purpose of this study was to prove whether the degree of venous tortuosity is significantly correlated with the aqueous VEGF concentration in CRVO eyes.

Methods: We reviewed the medical records of 19 eyes of 19 patients who had received an intravitreal injection of bevacizumab or ranibizumab for the macular edema due to CRVO at Nagoya University Hospital within 16 weeks of the onset. Aqueous humor was collected before the injections, and the VEGF concentration was measured by ELISA. The venous tortuosity index was calculated by dividing the arc length of the retinal veins by the chord length of the same segment. The correlation between the mean tortuosity index of the inferotemporal and supratemporal branches of the retinal vein and the aqueous VEGF concentration was determined.

Results: The mean VEGF concentration in the aqueous humor was 401 pg/ml with a range of 100 to 1320 pg/ml. The degree of venous tortuosity was significantly correlated with the VEGF concentration in the aqueous. (r=0.51, P=0.03, Spearman’s rank test).

Conclusions: The significant correlation between the venous tortuosity and the aqueous VEGF concentration indicates that the degree of retinal venous tortuosity can be used to predict the risk of NVI in CRVO eyes.

Keywords: 749 vascular occlusion/vascular occlusive disease • 748 vascular endothelial growth factor  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×